SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-028551
Filing Date
2023-06-06
Accepted
2023-06-06 16:30:23
Documents
12
Period of Report
2023-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20054100_8k.htm   iXBRL 8-K 35084
  Complete submission text file 0001140361-23-028551.txt   170722

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adma-20230606.xsd EX-101.SCH 3880
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20230606_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20230606_pre.xml EX-101.PRE 16054
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc20054100_8k_htm.xml XML 4059
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 23996481
SIC: 2836 Biological Products, (No Diagnostic Substances)